Showing results (71-80 of 101) with videos related to
Sort By:
Pageof 11
Postgraduate Medicine|March 23, 2025
Semaglutide 2.4 mg long-term clinical outcomes in patients with obesity or overweight: a real-world retrospective cohort study in the United States (SCOPE 12 months)Aleksandrina Ruseva, Firas Dabbous, Nina Ding, et al.Current Medical Research and Opinion|July 19, 2014
Real-world observations with prasugrel compared to clopidogrel in acute coronary syndrome patients treated with percutaneous coronary intervention in the United StatesJay P Bae, Douglas E Faries, Frank R Ernst, et al.American Journal of Health-System Pharmacy : AJHP : Official Journal of the American Society of Health-System Pharmacists|March 9, 2016
Comparative resource utilization and costs for patients with acute coronary syndrome managed with percutaneous coronary intervention and treated with clopidogrel or prasugrelJay P Bae, Douglas E Faries, Frank R Ernst, et al.Journal of Medical Economics|April 24, 2019
Reduced medical spending associated with increased use of a remote diabetes management program and lower mean blood glucose valuesChristopher M Whaley, Jennifer B Bollyky, Wei Lu, et al.Immunology|January 23, 2023
New role of gramicidin A in RIG-I-like receptors-mediated IFN signallingXiao Li, Xinyuan Sun, Zhongyi Yan, et al.Journal of the American Heart Association|August 21, 2016
Clinical Relevance of Rehospitalizations for Unstable Angina and Unplanned Revascularization Following Acute Myocardial InfarctionSupriya Shore, Kim G Smolderen, John A Spertus, et al.ACS Applied Materials & Interfaces|April 4, 2023
Rational Design of Highly Efficient PdIn-In2O3 Interfaces by a Capture-Alloying Strategy for Benzyl Alcohol Partial OxidationPeng Bai, Zhenxiang Zhao, Yonghui Zhang, et al.Expert Review of Pharmacoeconomics & Outcomes Research|January 12, 2026
Real-world healthcare resource utilization and medical costs in patients with overweight or obesity and multimorbidity treated with semaglutide in the United StatesPrachi Arora, Firas Dabbous, Sariya Udayachalerm, et al.Neurochemical Research|September 2, 2017
Capsaicin Protects Against Oxidative Insults and Alleviates Behavioral Deficits in Rats with 6-OHDA-Induced Parkinson's Disease via Activation of TRPV1ZhenXiang Zhao, JianFeng Wang, LingLing Wang, et al.Clinical Obesity|June 4, 2025
Estimating the association and timing of occurrence between obesity and related comorbidity outcomes in a real-world setting: A cohort study in the United StatesFiras Dabbous, Jigish Bhavsar, Jayashri Desai, et al.Pageof 11